Ibex Ltd (IBEX)
NASDAQ:IBEX
Want to see IBEX full AI Analyst Report?
Top Page
IBEX
(NASDAQ:IBEX)
Select Model
Select Model
Rating:72Outperform
Price Target:
$31.00
▲(8.32% Upside)
Action:ReiteratedDate:02/06/26
The score is driven primarily by improving fundamentals and a notably upbeat earnings call with raised guidance. Valuation is supportive at a ~12.3 P/E, while weaker technical momentum and some cash-flow/working-capital and vertical-mix risks temper the overall rating.
Positive Factors
Strong Revenue Momentum
IBEX delivered consecutive quarters of double-digit organic revenue growth and raised full-year revenue guidance, indicating durable client program expansion and sustained demand for outsourced CX. Raised guidance improves forward visibility and supports multi-month revenue planning and capacity investments.
Negative Factors
Cash-Flow Variability
Cash conversion has been inconsistent: FCF is materially below net income and recently turned negative due to higher capex and timing of training revenue. If this variability continues it could constrain reinvestment, reduce optionality for M&A or buybacks, and pressure liquidity over coming quarters.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong Revenue Momentum
IBEX delivered consecutive quarters of double-digit organic revenue growth and raised full-year revenue guidance, indicating durable client program expansion and sustained demand for outsourced CX. Raised guidance improves forward visibility and supports multi-month revenue planning and capacity investments.
Read all positive factors
IBEX (IBEX) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$432.87M
Dividend YieldN/A
Average Volume (3M)114.68K
Price to Earnings (P/E)6.8
Beta (1Y)1.06
Revenue Growth17.04%
EPS Growth45.20%
CountryUS
Employees33,000
SectorTechnology
Sector Strength88
IndustryInformation Technology Services
Share Statistics
EPS (TTM)N/A
Shares Outstanding13,389,116
10 Day Avg. Volume97,371
30 Day Avg. Volume114,676
Financial Highlights & Ratios
PEG Ratio0.36
Price to Book (P/B)3.18
Price to Sales (P/S)0.77
P/FCF Ratio15.65
Enterprise Value/Market Cap1.11
Enterprise Value/Revenue0.80
Enterprise Value/Gross Profit2.70
Enterprise Value/Ebitda6.64
Forecast
1Y Price Target
$40.00Price Target Upside39.76% Upside
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
IBEX Business Overview & Revenue Model
Company Description
IBEX Limited provides end-to-end technology-enabled customer lifecycle experience solutions in the United States and internationally. The company provides ibex Connect, a customer engagement solution that comprises customer service, technical supp...
How the Company Makes Money
IBEX primarily makes money by providing outsourced customer experience and business process services to enterprise clients under service contracts. Revenue is largely generated from operating contact center and CX programs (e.g., customer care, te...
IBEX Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
74
Positive
Cash Flow
66
Positive
| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 603.27M | 558.27M | 508.57M | 523.12M | 492.85M | 443.39M |
| Gross Profit | 178.43M | 172.58M | 152.03M | 148.13M | 118.88M | 108.14M |
| EBITDA | 72.43M | 64.80M | 60.96M | 60.10M | 38.77M | 31.16M |
| Net Income | 44.32M | 36.86M | 33.66M | 31.58M | 21.46M | 13.09M |
Balance Sheet | ||||||
| Total Assets | 295.80M | 273.21M | 293.90M | 293.32M | 294.18M | 274.29M |
| Cash, Cash Equivalents and Short-Term Investments | 15.46M | 15.35M | 62.72M | 57.43M | 48.83M | 57.84M |
| Total Debt | 64.34M | 69.75M | 67.02M | 78.90M | 105.54M | 112.52M |
| Total Liabilities | 141.28M | 138.91M | 128.10M | 143.36M | 180.72M | 193.63M |
| Stockholders Equity | 154.51M | 134.31M | 165.80M | 149.96M | 113.46M | 80.66M |
Cash Flow | ||||||
| Free Cash Flow | 29.28M | 27.29M | 27.05M | 22.91M | 14.09M | -4.75M |
| Operating Cash Flow | 59.08M | 45.67M | 35.90M | 41.86M | 40.01M | 16.08M |
| Investing Cash Flow | -29.80M | -18.38M | -8.86M | -19.04M | -25.92M | -20.82M |
| Financing Cash Flow | -33.96M | -74.66M | -21.73M | -13.61M | -22.13M | 40.90M |
IBEX Technical Analysis
Neutral
28.62
Price Trends
28.99
Positive
33.10
Negative
33.42
Negative
Market Momentum
-0.04
Negative
61.41
Neutral
89.47
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IBEX, the sentiment is Neutral. The current price of 28.62 is above the 20-day moving average (MA) of 27.82, below the 50-day MA of 28.99, and below the 200-day MA of 33.42, indicating a neutral trend. The MACD of -0.04 indicates Negative momentum. The RSI at 61.41 is Neutral, neither overbought nor oversold. The STOCH value of 89.47 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IBEX.
IBEX Risk Analysis
IBEX disclosed 49 risk factors in its most recent earnings report. IBEX reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
IBEX Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | $432.87M | 6.77 | 31.81% | ― | 17.04% | 45.20% | |
68 Neutral | $2.77B | 21.14 | 35.11% | ― | 40.10% | 2.61% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
59 Neutral | $590.02M | 6.26 | 21.23% | ― | 15.95% | 88.76% | |
58 Neutral | $337.45M | ― | 38.06% | ― | -12.59% | 33.81% | |
55 Neutral | $270.53M | 18.19 | 13.94% | 2.41% | -5.71% | -38.81% | |
48 Neutral | $231.84M | -1.04 | 126.78% | ― | 0.15% | -359.97% |
* Technology Sector Average
IBEX
IBEX
32.33
1.78
5.83%
INOD
Innodata
84.89
50.27
145.21%
HCKT
The Hackett Group
10.74
-13.40
-55.50%
UIS
Unisys
3.18
-1.67
-34.43%
TSSI
TSS
12.02
4.69
63.98%
TASK
TaskUs
6.45
-4.54
-41.31%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.